Tushar's Stock Tips: ISPY: Exploiting EternalBlue And BlueKeep Vulnerabilities With Metasploit Easier

About ISPY:
   ISPY is a Eternalblue (MS17-010) and BlueKeep (CVE-2019-0708) scanner and exploiter with Metasploit Framework.

   ISPY was tested on: Kali Linux and Parrot Security OS 4.7.

ISPY's Installation:
   For Arch Linux users, you must install Metasploit Framework and curl first:
pacman -S metasploit curl

   For other Linux distros not Kali Linux or Parrot Security OS. Open your Terminal and enter these commands to install Metasploit Framework:

   Then, enter these commands to install ISPY:

How to use ISPY?

ISPY's screenshots:

About the author:

On Github: @Cyb0r9
On Youtube: Cyborg
On Ask Fm: Cyborg
Email: TunisianEagles@protonmail.com

Disclaimer: Usage of ispy for attacking targets without prior mutual consent is illegal.
ispy is for security testing purposes only

Download ISPY

More information

Disclaimer

This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.

The information contained herein is from publicly available data or other sources believed to be reliable. While I would endeavour to update the information herein on reasonable basis, I am under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent me from doing so. I do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. I do not undertake to advise you as to any change of my views. I may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject me to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. I may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. I may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall I or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.